Reyoung Company Profile
✉ Email this page to a colleague
What is the competitive landscape for REYOUNG, and what generic and branded alternatives to REYOUNG drugs are available?
REYOUNG has five approved drugs.
Drugs and US Patents for Reyoung
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reyoung | FENOFIBRATE (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 207805-003 | Nov 16, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Reyoung | TENOFOVIR DISOPROXIL FUMARATE | tenofovir disoproxil fumarate | TABLET;ORAL | 211337-001 | Mar 2, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Reyoung | FENOFIBRATE (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 207805-002 | Nov 16, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Reyoung | NEBIVOLOL HYDROCHLORIDE | nebivolol hydrochloride | TABLET;ORAL | 212917-003 | Dec 17, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Reyoung | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 208494-001 | Jun 12, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Reyoung | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 208494-002 | Jun 12, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Reyoung | SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 078677-003 | Mar 4, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.